Interactions of NMDA antagonists and an α2, agonist with μ, δ and χ opioids in an acute nociception assay

Acta Anaesthesiologica Belgica

Volumn 53, Issue 3, 2002, Pages 203-212

  Baker, Alexis K ^a   Hoffmann, V L H ^a,b   Meert, T F ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Clonidine; Dextromethorphan; Fentanyl; Hot plate; Ketamine; Mice; Morphine; Nociception; SNC80 U50,488H; Sufentanil

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DELTA OPIATE RECEPTOR AGONIST; DEXTROMETHORPHAN; FENTANYL DERIVATIVE; KAPPA OPIATE RECEPTOR AGONIST; KETAMINE; MORPHINE; MORPHINE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL TISSUE; CALCULATION; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BINDING; DRUG DETERMINATION; DRUG EFFICACY; DRUG POTENCY; HOT PLATE TEST; LIPOPHILICITY; MALE; MOUSE; NOCICEPTION; NONHUMAN; REVIEW;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ADRENERGIC ALPHA-AGONISTS; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; CLONIDINE; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FENTANYL; KETAMINE; MALE; MICE; MORPHINE; N-METHYLASPARTATE; PAIN; PAIN MEASUREMENT; PIPERAZINES; REACTION TIME; RECEPTORS, OPIOID;

EID: 0036984305     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Adriaenssens G., Vermeyen K. M., Hoffmann V. L., Mertens E., Adriaensen H. F., Postoperative analgesia with i.v. patient-controlled morphine, effect of adding ketamine, BR. J. ANAESTH., 83, 393-396, 1999.
2. Advokat C., Rhein F. Q., Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan, BRAIN RES., 699, 157-160, 1995.
3. Bilsky E. J., Calderon S. N., Wang T., Bernstein R. N., Davis P., Hruby V. J., McNutt R. W., Rothman R. B., Rice K. C., Porreca F., SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist, J. PHARMACOL. EXP. THER., 273, 359-366, 1995.
4. Bonnet F., Boico O., Rostaing S., Saada M., Loriferne J. F., Touboul C., Abhay K., Ghignone M., Postoperative analgesia with extradural clonidine, BR. J. ANAESTH., 63, 465-469, 1989.
5. Bonnet F., Boico O., Rostaing S., Loriferne J. F., Saada M., Clonidine-induced analgesia in postoperative patients, epidural versus intramuscular administration, ANESTHESIOLOGY, 72, 423-427, 1990.
6. Bristow A., Orlikowski C., Subcutaneous ketamine analgesia, postoperative analgesia using subcutaneous infusions of ketamine and morphine, ANN. R. COLL. SURG. ENGL., 71, 64-66, 1989.
7. Calcagnetti D. J., Holtzman S. G., Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine, PHARMACOL. BIOCHEM. BEHAV., 38, 185-190, 1991.
8. Calderon S. N., Rothman R. B., Porreca F., Flippen-Anderson J. L., McNutt R. W., Xu H., Smith L. E., Bilsky E. J., Davis P., Rice K. C., Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80), a highly selective, nonpeptide delta opioid receptor agonist, J. MED. CHEM., 37, 2125-2128, 1994.
9. Chapman V., Dickenson A. H., The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn, BRAIN RES., 573, 321-323, 1992.
10. Chevlen E., Morphine with dextromethorphan, conversion from other opioid analgesics, JOURNAL OF PAIN & SYMPTOM MANAGEMENT, 19, S42-49, 2000.
11. Chia Y. Y., Liu K., Chow L. H., Lee T. Y., The preoperative administration of intravenous dextromethorphan reduces postoperative morphine consumption, ANESTH. ANALG., 89, 748-752, 1999.
12. Chou Y. C., Liao JF., Chang W. Y., Lin M. F., Chen C. F., Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan, BRAIN RES., 821, 516-519, 1999.
13. De Kock M. F., Pichon G., Scholtes J. L., Intraoperative clonidine enhances postoperative morphine patient-controlled analgesia, CAN. J. ANAESTH., 39, 537-544, 1992.
14. Dich-Nielsen J. O., Svendsen L. B., Berthelsen P., Intramuscular low-dose ketamine versus pethidine for postoperative pain treatment after thoracic surgery, ACTA ANAESTHESIOL. SCAND., 36, 583-587, 1992.
15. Edwards N. D., Fletcher A., Cole J. R., Peacock J. E., Combined infusions of morphine and ketamine for postoperative pain in elderly patients, ANAESTHESIA, 48, 124-127, 1993.
16. Eisenach J. C., Lysak S. Z., Viscomi C. M., Epidural clonidine analgesia following surgery, phase 1, ANESTHESIOLOGY, 71, 640-646, 1989a.
17. Eisenach J. C., Rauck R. L., Buzzanell C., Lysak S. Z., Epidural clonidine analgesia for intractable cancer pain, phase I, ANESTHESIOLOGY, 71, 647-652, 1989b.
18. Fisher A., Biggs C. S., Starr M. S., Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat, BRAIN RES., 792, 126-132, 1998.
19. Grass S., Hoffmann O., Xu X. J., Wiesenfeld Hallin Z., N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat, ACTA PHYSIOL. SCAND., 158, 269-273, 1996.
20. Han J. S., Xie G. X., Goldstein A., Analgesia induced by intrathecal injection of dynorphin B in the rat, LIFE SCI., 34, 1573-1579, 1984.
21. Handa E, Tanaka M., Nishikawa T., Toyooka H., Effects of oral clonidine premedication on side effects of intravenous ketamine anesthesia, a randomized, doubleblind, placebo-controlled study, J. CLIN. ANESTH., 12, 19-24, 2000.
22. Hoffman B. B., Lefkowitz R. J., Cathecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, New York, McGraw-Hill, 1996.
23. Ilkjaer S., Dirks J., Brennum J., Wernberg M., Dahl J. B., Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans, BR. J. ANAESTH., 79, 600-605, 1997.
24. Ilkjaer S., Bach L. F., Nielsen P. A., Wernberg M., Dahl J. B., Effect of preoperative oral dextromethorphan on immediate and late postoperative pain and hyperalgesia after total abdominal hysterectomy, PAIN, 86, 19-24, 2000.
25. Jahangir S. M., Islam F., Aziz L., Ketamine infusion for postoperative analgesia in asthmatics, a comparison with intermittent meperidine, ANESTH. ANALG., 76, 45-49, 1993.
26. Javery K. B., Ussery T.W., Steger H. G., Colclough G. W., Comparison of morphine and morphine with ketamine for postoperative analgesia, CAN. J. ANAESTH., 43, 212-215, 1996.
27. Jhamandas K., Sutak M., Lemaire S., Comparative spinal analgesic action of dynorphin1-8, dynorphin1-13, and a kappa-receptor agonist U50,488, CAN. J. PHYSIOL. PHARMACOL., 64, 263-268, 1986.
28. Kamei J., Saitoh A., Ohsawa M., Suzuki T., Misawa M., Nagase H., Kasuya Y., Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice, EUR. J. PHARMACOL., 276, 131-135, 1995.
29. Karim F., Roerig S. C., Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists, PAIN, 87, 181-191, 2000.
30. Kariya N., Shindoh M., Nishi S., Yukioka H., Asada A., Oral clonidine for sedation and analgesia in a burn patient, J. CLIN. ANESTH., 10, 514-517, 1998.
31. Kawamata T., Omote K., Kawamata M., Namiki A., Premedication with oral dextromethorphan reduces postoperative pain after tonsillectomy, ANESTH. ANALG., 86, 594-597, 1998.
32. Kinnman E., Nygards E. B., Hansson P., Effects of dextromethorphan in clinical doses on capsaicin-induced ongoing pain and mechanical hypersensitivity, J. PAIN SYMPTOM MANAGE, 14, 195-201, 1997.
33. Knapp R. J., Santoro G., De Leon I. A., Lee K. B., Edsall S. A., Waite S., Malatynska E., Varga E., Calderon S. N., Rice K. C., Rothman R. B., Porreca F., Roeske W. R., Yamamura H. I., Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors, J. PHARMACOL. EXP. THER., 277, 1284-1291, 1996.
34. Kovacs G. L., Nyolczas N., Krivan M., Gulya K., Analgesic and tolerance-inducing effects of the highly selective delta opioid agonist [D-Pen2,D-Pen5] enkephalin in mice, EUR. J. PHARMACOL., 150, 347-353, 1988.
35. Kress H. G., [Mechanisms of action of ketamine], ANAESTHESIST, 46, S8-19, 1997.
36. Lameh J., Eiger S., Sadee W., Interaction among mu-opioid receptors and alpha 2-adrenoceptors on SH-SY5Y human neuroblastoma cells, EUR. J. PHARMACOL., 227, 19-24, 1992.
37. Lipton S. A., Prospects for clinically tolerated NMDA antagonists, open channel blockers and alternative redox states of nitric oxide, TRENDS PHARMACOL. SCI., 16, 527-532, 1993.
38. Mao J., Price D. D., Hayes R. L., Lu J., Mayer D. J., Frenk H., Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy, BRAIN RES., 605, 164-168, 1993.
39. McQuay H. J., Carroll D., Jadad A. R., Glynn C. J., Jack T., Moore R. A., Wiffeh P. J., Dextromethorphan for the treatment of neuropathic pain, a double-blind randomised controlled crossover trial with integral n-of 1 design, Pain, 59, 127-133, 1994.
40. Meert T. F., De Kock M., Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats, ANESTHESIOLOGY, 81, 677-688, 1994.
41. Meert T. F., Pharmacotherapy of opioids, present and future developments, PHARMACY WORLD & SCIENCE, 18, 1-15, 1996.
42. Mendez R., Eisenach J. C., Kashtan K., Epidural clonidine analgesia after cesarean section, ANESTHESIOLOGY, 73, 848-852, 1990.
43. Negus S. S., Henriksen S. J., Mattox A., Pasternak G. W., Portoghese P. S., Takemori A. E., Weinger M. B., Koob G. F., Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats, J. PHARMACOL. EXP. THER., 265, 1245-1252, 1993.
44. Negus S. S., Gatch M. B., Mello N. K., Zhang X., Rice K., Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys, J. PHARMACOL. EXP. THER., 286, 362-375, 1998.
45. Nishimura M., Sato K., Ketamine stereoselectively inhibits rat dopamine transporter, NEUROSCI. LETT., 274, 131-134, 1999.
46. Ossipov M. H., Harris S., Lloyd P., Messineo E., An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates, J. PHARMACOL. EXP. THER., 255, 1107-1116, 1990.
47. Pande A. C., Pyke R. E., Greiner M., Cooper S. A., Benjamin R., Pierce M. W., Analgesic efficacy of the kappa-receptor agonist, enadoline, in dental surgery pain, CLLN. NEUROPHARMACOL., 19, 92-97, 1996a.
48. Pande A. C., Pyke R. E., Greiner M., Wideman G. L., Benjamin R., Pierce M. W., Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain, CLIN. NEUROPHARMACOL., 19, 451-456, 1996b.
49. Parkhouse J., Marriott G., Postoperative analgesia with ketamine andpethidine, ANAESTHESIA, 32, 285-289, 1977.
50. Piercey M. E, Lahti R. A., Schroeder L. A., Einspahr E J., Barsuhn C., U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse, LIFE Sci., 31, 1197-1200, 1982a.
51. Piercey M. F., Vamer K., Schroeder L. A., Analgesic activity of intraspinally administered dynorphin and ethylketocyclazocine, EUR. J. PHARMACOL., 80, 283-284, 1982b.
52. Plesan A., Hedman U., Xu X. J., Wiesenfeld-Hallin Z., Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats, ANESTH. ANALG., 86, 825-829, 1998.
53. Plesan A., Sollevi A., Segerdahl M., The N-methyl-D-aspartate-receptor antagonist dextromethorphan lacks analgesic effect in a human experimental ischemic pain model, ACTA ANAESTHESIOL. SCAND., 44, 924-928, 2000.
54. Price D. D., Mao J., Frenk H., Mayer D. J., The N-methyl-Daspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man, PAIN, 59, 165-174, 1994.
55. Roerig S. C., Hoffman R. G., Takemori A. E., Wilcox G. L., Fujimoto J. M., Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice, J. PHARMACOL. EXP. THER., 257, 1091-1099, 1991.
56. Roerig S. C., Lei S., Kitto K., Hylden J. K., Wilcox G. L., Spinal interactions between opioid and noradrenergic agonists in mice, multiplicativity involves delta and alpha-2 receptors, J. PHARMACOL. EXP. THER., 262, 365-374, 1992.
57. Rose J. B., Cuy R., Cohen D. E., Schreiner M. S., Preoperative oral dextromethorphan does not reduce pain or analgesic consumption in children after adenotonsillectomy, ANESTH. ANALG., 88, 749-753, 1999.
58. Schmid R. L., Sandler A. N., Katz J., Use and efficacy of lowdose ketamine in the management of acute postoperative pain, a review of current techniques and outcomes, PAIN, 82, 111-125, 1999.
59. Segal I. S., Jarvis D. J., Duncan S. R., White P. F., Maze M., Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period, ANESTHESIOLOGY, 74, 220-225, 1991.
60. Sethna N. F., Liu M., Gracely R., Bennett G. J., Max M. B., Analgesic and cognitive effects of intravenous ketaminealfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects, ANESTH. ANALG., 86, 1250-1256, 1998.
61. Stewart P. E., Hammond D. L., Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat, J. PHARMACOL. EXP. THER., 268, 701-708, 1994.
62. Striebel W. H., Koenigs D. I., Kramer J. A., Intravenous clonidine fails to reduce postoperative meperidine requirements, J. CLIN. ANESTH., 5, 221-225, 1993.
63. Taittonen M. T., Kirvela O. A., Aantaa R., Kanto J. H., The effect of clonidine or midazolam premedication on perioperative responses during ketamine anesthesia, ANESTH. ANALG., 87, 161-167, 1998.
64. Tal M., Bennett G. J., Dextrorphan relieves neuropathic heatevoked hyperalgesia in the rat, NEUROSCI. LETT., 151, 107-110, 1993.
65. Verborgh C. M., Camu F., Meert T. F., Interaction between sufentanil and U-50488H with respect to antinociception and respiratory depression in rats, ACTA ANAESTHESIOL. SCAND., 41, 895-902, 1997.
66. Wadhwa A., Clarke D., Goodchild C. S., Young D., Large-dose oral dextromethorphan as an adjunct to patient-controlled analgesia with morphine after knee surgery, ANESTH. ANALG., 92, 448-454, 2001.
67. Wakita K., The antinociceptive effects of fentanyl, midazolam and clonidine and their interactions in the spinal dorsal horn, MASUI - JAPANESE JOURNAL OF ANESTHESIOLOGY, 41, 1881-1888, 1992.
68. Warncke T., Stubhaug A., Jorum E., Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man, PAIN, 86, 293-303, 2000.
69. White P. F., Way W. L., Trevor A. J., Ketamine - its pharmacology and therapeutic uses, ANESTHESIOLOGY, 56, 119-136, 1982.
70. Wilcox G. L., Carlsson K. H., Jochim A., Jurna I., Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord, BRAIN RES., 405, 84-93, 1987.
71. Wong C. S., Liaw W. J., Tung C. S., Su Y. E, Ho S. T., Ketamine potentiates analgesic effect of morphine in postoperative epidural pain control, REG. ANESTH., 21, 534-541, 1996.
72. Yaksh T. L., Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray, BRAIN RES., 160, 180-185, 1979.
73. Yaksh T. L., Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing, PHARMACOL. BIOCHEm. BEHAV., 22, 845-858, 1985.
74. Yamamoto T., Yaksh T. L., Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy, NEUROSCI. LETT., 135, 67-70, 1992